Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on bardoxolone methyl for pulmonary arterial hypertension, including detailed descriptions of the study's methodology, inclusion and exclusion criteria, and the study sponsor's information. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference33%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.